Find Articles



Return to:Arthritis Articles
Or:Recent Arthritis Articles

Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical ...


http://www.forbes.com/prnewswire/feeds/prnewswire/2007/10...

Forbes - ... MT203, Micromet's human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis ...



Article Finder:

October 18, 2007 04:06:00 AM
Article Directory